These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2544499)

  • 1. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma.
    Kanematsu T; Furuta T; Takenaka K; Matsumata T; Yoshida Y; Nishizaki T; Hasuo K; Sugimachi K
    Hepatology; 1989 Jul; 10(1):98-102. PubMed ID: 2544499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration].
    Shirabe K; Kanematsu T; Utsunomiya T; Furuta T; Yamagata M; Matsumata T; Sugimachi K; Yasumori K; Masuda K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2974-7. PubMed ID: 2551238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
    Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective effects of Lipiodolized antitumor agents.
    Kanematsu T; Inokuchi K; Sugimachi K; Furuta T; Sonoda T; Tamura S; Hasuo K
    J Surg Oncol; 1984 Mar; 25(3):218-26. PubMed ID: 6199624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma.
    Furuta T; Kanematsu T; Matsumata T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):494-7. PubMed ID: 2174829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
    Takenaka K; Yoshida K; Nishizaki T; Korenaga D; Hiroshige K; Ikeda T; Sugimachi K
    Am J Surg; 1995 Apr; 169(4):400-4; discussion 405. PubMed ID: 7694977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
    Lu CD; Qi YG; Peng SY
    Chin Med J (Engl); 1994 Mar; 107(3):209-15. PubMed ID: 8088182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma.
    Matsui Y; Figi A; Horikawa M; Jahangiri Noudeh Y; Tomozawa Y; Hashimoto K; Kaufman JA; Farsad K
    Diagn Interv Imaging; 2017 Dec; 98(12):827-835. PubMed ID: 29157897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call(®)) in patients with unresectable hepatocellular carcinoma.
    Yamashita Y; Taketomi A; Itoh S; Harimoto N; Morita K; Fukuhara T; Ueda S; Sanefuji K; Sugimachi K; Tajima T; Maehara Y
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):301-7. PubMed ID: 19495755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial embolization for advanced hepatocellular carcinoma resulting in a curative resection: report of two cases.
    Mizoe A; Yamaguchi J; Azuma T; Fujioka H; Furui J; Kanematsu T
    Hepatogastroenterology; 2000; 47(36):1706-10. PubMed ID: 11149037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T; Maeda H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
    Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
    Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
    Jang JW; Choi JY; Bae SH; Kim CW; Yoon SK; Cho SH; Yang JM; Ahn BM; Lee CD; Lee YS; Chung KW; Sun HS
    J Hepatol; 2004 Sep; 41(3):427-35. PubMed ID: 15336446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeting anticancer chemotherapy dispersed in lipid contrast medium in hepatoblastoma in childhood].
    Ohnuma N; Takahashi H; Tanabe M; Yoshida H; Iwakawa M; Kuriyama Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):788-92. PubMed ID: 2164551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative randomized trial of intermittent intrahepatic arterial carboplatin- versus doxorubicin-lipiodol emulsion in advanced hepatocellular carcinoma (stage IV).
    Homma H; Mezawa S; Doi T; Miyanishi K; Takada K; Kukitsu T; Oku T; Masuko E; Nojiri S; Niitsu Y
    Hepatogastroenterology; 2004; 51(58):1135-9. PubMed ID: 15239261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lipiodolization on a cirrhotic liver.
    Nishizaki T; Takenaka K; Yoshida K; Ikeda T; Sugimachi K
    J Surg Oncol; 1995 Apr; 58(4):263-8. PubMed ID: 7723371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma.
    Katagiri Y; Mabuchi K; Itakura T; Naora K; Iwamoto K; Nozu Y; Hirai S; Ikeda N; Kawai T
    Cancer Chemother Pharmacol; 1989; 23(4):238-42. PubMed ID: 2538250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic arterial lipiodolization and x-ray computed tomography diagnosis of malignant liver tumors. Experience apropos of 33 cases].
    Puech JL; Rousseau H; Portalez D; Fourtanier G; Bugat R; Marty MH; Joffre F
    Ann Radiol (Paris); 1987; 30(3):193-201. PubMed ID: 3039898
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.
    Kalayci C; Johnson PJ; Raby N; Metivier EM; Williams R
    J Hepatol; 1990 Nov; 11(3):349-53. PubMed ID: 1705275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.